Physician profile
Abdullah Baig
NPI 1538126784
$8,430.53
in general payments reported to CMS, 2019-2025
52 companies · $728 in 2025
The $728 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,396 · 2020: $2,046 · 2021: $1,296 · 2022: $1,226 · 2023: $902 · 2024: $838 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,467.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,437.66 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $859.31 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals Lp | $678.85 | 2019-2025 | Breztri, Evusheld, Airsupra |
| Amgen INC. | $561.70 | 2020-2025 | Repatha, Otezla, Repatha |
| Astellas Pharma US INC | $501.01 | 2020-2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $483.80 | 2021-2025 | |
| Glaxosmithkline, LLC. | $417.64 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Nestle Healthcare Nutrition INC. | $414.16 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $334.43 | 2019-2025 | Jardiance, Stiolto Respimat |
| Merck Sharp & Dohme LLC | $322.44 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $252.07 | 2019-2022 | |
| Abbvie INC. | $222.04 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Pfizer INC. | $216.12 | 2019-2024 | |
| Allergan, INC. | $164.43 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $126.56 | 2019-2023 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $119.77 | 2021-2025 | Freestyle Libre 3 |
| Philips North America LLC | $88.46 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Takeda Pharmaceuticals U.S.A., INC. | $82.49 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $79.11 | 2022-2023 | Seglentis |
| E.R. Squibb & Sons, L.L.C. | $78.35 | 2019-2023 | Eliquis |
| Phathom Pharmaceuticals, INC. | $64.06 | 2024 | Voquezna |
| Vanda Pharmaceuticals INC. | $63.84 | 2020 | |
| Mylan Specialty L.P. | $62.97 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $62.45 | 2023-2025 | Gemtesa |
| Mannkind Corporation | $45.55 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.31 | 2022 | |
| Exact Sciences Corporation | $44.71 | 2023-2024 | Cologuard Collection Kit |
| Fidia Pharma USA INC. | $41.81 | 2025 | Hymovis, Hyalgan |
| Viatris Specialty LLC | $32.94 | 2025 | Yupelri |
| Inogen, INC. | $32.28 | 2023 | Inogen At Home Stationary Concentrator, Inogen One G5 Oxygen Concentrator - Bluetooth |
| Arbor Pharmaceuticals, INC. | $32.10 | 2019-2021 | |
| Averitas Pharma INC. | $31.88 | 2025 | Qutenza |
| Baxter Healthcare | $30.04 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Alkermes, INC. | $28.89 | 2024 | Aristada, Lybalvi |
| Evoke Pharma, INC. | $19.96 | 2021 | |
| Hologic Sales and Service, LLC | $19.38 | 2020 | |
| Eisai INC. | $18.85 | 2021 | |
| Esperion Therapeutics, INC. | $18.08 | 2021 | |
| Shield Therapeutics INC | $18.05 | 2023 | Accrufer |
| Gilead Sciences, INC. | $16.80 | 2020 | |
| Seqirus USA INC | $16.75 | 2022 | |
| Avanir Pharmaceuticals, INC. | $16.22 | 2020 | |
| Dexcom, INC. | $15.66 | 2020 | |
| Edwards Lifesciences Corporation | $15.19 | 2025 | Sapien 3 Ultra Resilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.95 | 2020 | |
| Vifor Pharma, INC. | $13.32 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.81 | 2021 | |
| Dermira, INC. | $12.20 | 2020 | |
| Scynexis, INC. | $11.77 | 2022 | |
| Nabriva Therapeutics, Plc | $11.65 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.63 | 2020 | |
| Corium, LLC | $7.03 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdullah Baig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.